期刊文献+

弓形虫复合黏膜疫苗滴鼻免疫小鼠诱导NALT和GALT黏膜部位的免疫应答 被引量:2

Intranasal Immunization with Mucosal Complex Vaccine for Toxoplasma gondii Induces Local Immune Responses in Both NALT and GALT
下载PDF
导出
摘要 目的观察弓形虫复合黏膜疫苗滴鼻免疫小鼠诱导的鼻相关淋巴组织(NALT)和肠相关淋巴组织(GALT)黏膜部位的免疫应答,探讨弓形虫黏膜疫苗能否在感染起始阶段有效诱导免疫应答。方法将BALB/c小鼠随机分为免疫和对照组,免疫组小鼠以弓形虫复合黏膜疫苗20μl/只(20μgSTAg+1μgCT)滴鼻免疫2次(间隔2周),对照组PBS滴鼻。于末次滴鼻后14d颈椎脱臼处死小鼠,ELISA测定粪便和鼻咽冲洗液IgA抗体水平;计数NALT、NC及PP、IEL淋巴细胞数,免疫细胞化学法检测CD4+、CD8+T细胞亚群水平。结果免疫组小鼠粪便IgA和鼻咽冲洗液IgA抗体显著高于对照组(P<0.05)。NALT内淋巴细胞明显增生(P<0.05),其中CD4+、CD8+T细胞均有增生(P<0.01),CD4+/CD8+比值降低(P<0.05)。NC中淋巴细胞数明显升高(P<0.01),以CD4+T细胞水平为主(P<0.01)。GALT部位PP淋巴细胞增生显著(P<0.01),主要以CD4+T细胞为主;而IEL以CD8+T细胞增生为主(P<0.01),CD4+/CD8+比值降低(P<0.05)。结论弓形虫复合黏膜疫苗滴鼻免疫BALB/c小鼠可有效诱导NALT和GALT黏膜部位免疫应答。 Objective To study the local immune response in NALT and GALT after intranasal immunization with mucosal complex vaccine for Toxoplasma Bond/i, and to determine whether intranasal (i.n) immunization is an effective route for Toxoplasma gondii mucosal vaccine. Methods BALB/c mice were randomly divided into two groups: immunized group and control group. Mice were immunized (i.n) with 20 μl mucosal complex vaccine (20 μg STAg+1μg CT) twice at an internal of two weeks, while the control mice were given with PBS. Mice were sacrificed on day-14 after the last immunization. IgA antibodies in feces and nasopharynx washes were detected by ELISA. Lymphocytes in NALT,NC,PP and IEL were isolated and counted. Percentage of CD4^+ and CD8^+ T cells was determined by imm,mocytochemistry. Results IgA antibodies in feces and nasopharynx washes of immunized mice were higher than the control group (P〈 0.05). The number of lymphocytes in NALT was significantly increased after immunization (P〈0.05). The numbers of CD4^+ and CD8^+ T cells were both higher than the control (P〈0.01), while the ratio of CD4^+ to CD8^+ T was decreased (P〈0.05). The number of lymphocytes in NC and PP significantly increased (P〈0.01), and the increase was mainly due to the increase of CD4^+ T ceils (P〈0.01). For IEL, there was a predominant number of CD8^+ T increasing significantly (P〈0.01), and the ratio of CD4^+ and CD8^+ T cells was reversed with significance (P〈0.05). Conclusion Intranasal immunization with mucosal complex vaccine for Toxoplasma gondii can effectively induce immune responses into both NALT and GALT compartments. And intranasal immunization is an effective route for Toxoplasma Bondii mucesal vaccine.
出处 《热带医学杂志》 CAS 2007年第1期3-6,共4页 Journal of Tropical Medicine
基金 国家自然科学基金(No.30640057) 山西省自然科学基金(No.20041105) 山西省高校科技研究开发项目(No.20041238) 山西医科大学基础医学院"学科研究方向建设基金"(No.20040708)。
关键词 弓形虫 黏膜疫苗 滴鼻免疫 鼻相关淋巴组织 肠相关淋巴组织 Toxoplasma gondii mucosalvaceine intranasal immunization NALT GALT
  • 相关文献

参考文献16

  • 1HOLMGREN J,CZERKINSKY C.Mucosal immunity and vaccines[J].Nat Med,2005,11 (4 Suppl):S45-53.
  • 2刘龙丁,曹逸云.疫苗设计的技术基础[M]//董德祥,主编.疫苗技术基础与应用.北京:化学工业出版社,2002:44-73.
  • 3STANLEY AC,HUNTLEY JF,JEFFREY M,et al.Characterization of ovine nasal-associated lymphoid tissue and identification of M cells in the overlying follicle-associated epithelium[J].Comp Pathol,2001,125(4):262-270.
  • 4HERITAGE PL,UNDERDOWN BJ,ARSENAULT AL,et al.Comparison of murine nasal-associated lymphoid tissue and Peyer's patches[J].Am J Respir Crit Care Med,1997,156(4 Pt 1):1256-1262.
  • 5BYUN Y,OHMURA M,FUJIHASHI K,et al.Nasal immunization with E.coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies[J].Vaccine,2001,19(15-16):2061-2070.
  • 6KASPER L,COURRET N,DARCHE S,et al.Toxoplasma gondii and mucosal immunity[J].Int J Parasitol,2004,34(3):401-409.
  • 7SUSANTO L,MULJONO RP.Preparation of Toxoplasma gondii RH strain antigen,antigen analysis and antigen detection in sera:a review[J].Southeast Asian J Trop Med Public Health,2001,32(Suppl 2):195-201.
  • 8殷国荣,元海军,杨亚波,周永安,沈嬿琼,孟晓丽.TSo联合IFN-γ鼻内免疫小鼠诱导的弓形虫IgA抗体特异性免疫应答[J].热带医学杂志,2004,4(6):670-673. 被引量:25
  • 9舒翠莉,彭虹,王华,陈洁,高杰英.滴鼻免疫有效的诱导粘膜及系统免疫反应[J].微生物学免疫学进展,2001,29(4):40-44. 被引量:10
  • 10ASANUMA H,THOMPSON AH,IWASAKI T,et al.Isolation and characterization of mouse nasal-associated lymphoid tissue[J].J Immunol Methods,1997,202:123-131.

二级参考文献17

  • 1Halina Wedrychowicz,舒衡平.胃肠道寄生虫感染中的分泌型IgA[J].国外医学(寄生虫病分册),1996,23(4):156-158. 被引量:2
  • 2舒翠莉 高杰英 等.双价痢疾菌苗滴鼻免疫诱导 不同粘膜部位的免疫反应[J].中国免疫学杂志,2000,16:25-28.
  • 3舒翠莉 高杰英 等.鼻粘膜相关淋巴组织和鼻通道淋巴细胞的分离与初步鉴定[J].中国免疫学杂志,2000,16:1-6.
  • 4[4]Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases[J]. Rev Med Virol, 2001, 11(2): 117- 133.
  • 5[5]Lloyd Kaspera, Nathalie Courretb, Sylvie Darchec, et al. Toxoplasma gondii and mucosal immunity[J]. Int J for Parasitol,2004, 34:401- 409.
  • 6[6]Briskin M, Winsor HD, Shyjan A, et al. Human mucosal addressin cell adhesion molecule is preferentially expressed in intestinal tract and associated lymphoid tissue [J]. Am J Pathol, 1997, 151:97- 110.
  • 7[7]Suzuki Y. IFN-γ : the major mediator of resistance against Toxoplasma gondii [J]. Science, 1988, 240:516- 523.
  • 8[9]Debard N, Buzoni- Gatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebal cyst after oral infection[J]. Infect Immun, 1996, 64 (6): 2158- 2166.
  • 9[10]Velge- Roussel F, Marcelo P, Bout DT, et al. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments[J]. Infect Immun, 2000, 68 (2): 969- 972.
  • 10[11]Bonenfant C, Dimier- Poisson I, Velge- Roussel F, et al. Intranasal I immunization with SAG1 and nontoxic mutant heat- labile enterotoxins protects mice against Toxoplasma gondii [J]. Infect Immun, 2001, 69(4): 1605- 1612.

共引文献34

同被引文献20

  • 1殷国荣,元海军,杨亚波,周永安,沈嬿琼,孟晓丽.TSo联合IFN-γ鼻内免疫小鼠诱导的弓形虫IgA抗体特异性免疫应答[J].热带医学杂志,2004,4(6):670-673. 被引量:25
  • 2孟晓丽,殷国荣,刘红丽,石蓉,张宇斌,马秀瑞.不同剂量STAg滴鼻免疫小鼠诱导的抗弓形虫感染作用[J].中国人兽共患病学报,2006,22(3):202-205. 被引量:31
  • 3孟晓丽,殷国荣,杨亚波,唐旭,吴静,马广源.弓形虫复合黏膜疫苗滴鼻免疫小鼠诱导的特异性抗体动态观察[J].中国生物制品学杂志,2007,20(1):51-53. 被引量:17
  • 4Mora JR, yon Andfian UH. Differentiation and homing of IgA-secreting cells[J]. Mucosal Immunol, 2008, 1(2): 96-109.
  • 5Mordue DG, Monroy F, La Regina M, et al. Acute toxoplasmosis leads to lethal overproduction of Thl cytokines[J]. J Immunol, 2001, 167(8): 4574-4584.
  • 6Schreiner M, Liesenfeld O. Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BIJ6 mice: review of 70 reports from the literature[J]. Mem Inst Oswaldo Cruz, 2009, 104(2): 221-233.
  • 7Knop E, Knop N, Claus P. Local production of secretory IgA in the eye-associated lymphoid tissue (EALT) of the normal human ocular surface[J]. Invest Ophthalmol Vis Sei, 2008, 49(6): 2322- 2329.
  • 8Griffiths EA, Duffy LC, Schanbacher FL, et al. In vivo effect of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in BALB/c mice[J]. Dig Dis Sci, 2004, 49(4) : 579-589.
  • 9Devito C, Zuber B, Schroder U, et al. Intranasal HIV-1-gp160- DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity[J]. J Immunol, 2004, 173(11): 7078-7089.
  • 10Boncnfant C, Dimier-Poisson I, Velge-Roussel F, et ol. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii[J]. Infect Immun, 2001, 69(3): 1605-1612.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部